Farmakoterapi Gangguan Anxietas

HILDA VILDAYANTI, Irma Melyani Puspitasari, Rano Kurnia Sinuraya

Abstrak


Gangguan anxietas merupakan gangguan yang paling umum terjadi yang berkaitan dengan mental, emosional dan perilaku. Gangguan anxietas ditandai dengan kecemasan yang berlebihan dan tidak realistis mengenai suatu hal. Menurut survei epidemiologi, sepertiga penduduk dunia dipengaruhi oleh gangguan anxietas selama masa hidupnya. Penentuan jenis gangguan anxietas diperlukan untuk memastikan pengobatan yang sesuai dengan jenis gangguannya. Review artikel ini bertujuan untuk memberikan informasi mengenai perkembangan pengobatan yang digunakan pada penderita gangguan anxietas berdasarkan tipe gangguannya. Sumber data yang digunakan untuk dijadikan referensi pada review artikel ini terdiri dari 20 jurnal ilmiah, 5 textbook, dan 2 website resmi yaitu National Institute of Mental Health dan Ministry of Health. Pengobatan untuk gangguan anxietas mencakup berbagai antidepresan (SSRIs, SNRIs, TCAs, dan MAOIs), anti-anxietas (benzodiazepin dan buspiron), serta β-blockers. Berdasarkan beberapa guideline, SSRIs direkomendasikan sebagai first-line terapi untuk sebagian besar gangguan anxietas.

Kata kunci: Gangguan Anxietas, Tipe Anxietas, Farmakoterapi


Teks Lengkap:

PDF

Referensi


Baldwin, D.S., Anderson, I.M., Nutt, D.J., Allgulander, C., Bandelow, B., Christmas, D.M. 2014. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology: 1-37.

Bandelow, B., Michaelis, S. 2015. Epidemiology of Anxiety Disorders in the 21st Century. Journal NCBI, Dialogues in Clinical Neuroscience, 17(3): 327-335.

Bandelow, B., Sophie, M., Dirk, W. 2017. Treatment of Anxiety Disorders. Journal NCBI, Dialogues in Clinical Neuroscience, 19(2): 93-107.

Bener, A., Ghuloum, S., Abou-Saleh, M.T. 2012. Prevalence, Symptom Patterns and Comorbidity of Anxiety and Depressive Disorders in Primary Care in Qatar. Soc Psychiatry Psychiatr Epidemiol, 47(3): 439–46.

Bystritsky, A., Sahib, S. K., Michael, E. C., Jason, S. 2013. Current Diagnosis and Treatment of Anxiety Disorders. Pharmacy and Therapeutics, 38(1): 41-44.

Christmas, D., Nutt, D. 2008. Potential Novel Anxiolytic Drugs. Current Pharmaceutical Design, 14: 3534-46.

DiPiro, J.T., Wells, B.G., Schwinghammer, T.L., DiPiro, C.V. 2009. Pharmacotherapy Handbook, Seventh Edition. New York: McGraw-Hill.

DiPiro, J.T., Wells, B.G., Schwinghammer, T.L., DiPiro, C.V. 2015. Pharmacotherapy Handbook, Ninth Edition. New York: McGraw-Hill.

Dogaheh, E.R. 2013. Psychometric Properties oif Farsi Version of the Social Phobia Inventory (SPIN). Social and Behavioral Science, 84: 763-763.

Kampfe, C.K., Gloster, A.T., Wittchen, H.U., Helbig-Lang, S., Lang, T., Gerlach, A.L., et al. 2012. Experimental Avoidance and Anxiety Sensitivity in Patient with Panic Disorder and Agoraphobia. International Journal of Clinical and Health Psychology, 12(1): 5-22.

Katzman, M.A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Ameringen, M.V. 2014. Canadian Clinical Practice Guideline for the Management of Anxiety, Posttraumatic Stress and Obsessive-compulsive Disorders. BMC Psychiatry, 14(1).

Kessler, R. C., Wang, P.S. 2008. The Descriptive Epidemiology of Commonly Occuring Mental Disorders in the United States. Annual Review of Public Health, 29: 115-129.

Locke, B. L., Nell, K., Cameron, G. S. 2015. Diagnosis and Management of Generalized Anxiety Disorder and Panic Disorder in Adults. American Family Physician, 91(9).

Lopez, G., Artigas, F., Adell, A. 2010. Unraveling monoamine receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex. Curr Pharm, 16(5): 502-15.

Lowe, B., Decker, O., Muller, S., Brahler, E., Schellberg, D., Herzog, W., et al. 2008. Validation and Standardization of the Generalzed Anxiety Disorder Screener (GAD-7) in the General Population, Medical Care, 46(3): 266-274.

Maideen, S.F.K., Sidik, S.M., Rampal, L., Mukhtar, F. 2015. Prevalence, Associated Factors and Predictors of Anxiety: a Community Survey in Selangor, Malaysia. BMC Psychiatry, 15: 262.

Mathew, J.S., Rebecca, B.P., Dennis, S.C. 2008. Recent Advances in the Neurobiology of Anxiety Disorders: Implications for Novel Therapeutics. American Journal of Medical Genetics, 148: 89-98.

McEvoy, P.M., R. Grove., T. Slade. 2011. Epidemiology of Anxiety Disorders in the Australian General Population: Findings of the 2007 Australian National Survey of Mental Health and Wellbeing. Australian & New Zealand Journal of Psychiatry, 45(11): 957-967.

Meng, X., Arcy, C. 2012. Common and Unique Risk Factors and Comorbidity for 12-Month Mood and Anxiety Disorders Among Canadians. The Canadian Journal of Psychiatry, 57: 479-87.

Ministry of Health. 2015. Clinical Practice Guidelines: Anxiety Disorders. Singapore. Available online at https://www.moh.gov.sg/content/dam/moh_web/HPP/Doctors/cpg_medical/current/2015/anxiety_disorders/cpg_Anxiety%20Disorders%20%20Apr%202015%20-%20Full%20Guidelines.pdf.

National Institute of Mental Health. 2009. Anxiety Disorders. Available online at https://www.nimh.nih.gov/health/topics/anxiety-disorders/index.shtml.

Simpson, H.B., Y. Neria., R. Lewis-Fernandez., F. Schneiner. 2010. Anxiety Disorder-Theory, Research and Clinical Perspective, 1st Ed. Cambridge: Cambridge University Press.

Soodan, S., Arya, A. 2015. Understanding the Pathophysiology and Management of the Anxiety Disorders. International Journal of Pharmacy & Pharmaceutical Research, 4(3): 251-278.

Stuart, G.W. 2012. Buku Saku Keperawatan Jiwa, Edisi 5. Jakarta: EGC.

Videbeck, S.L. 2011. Psychiatric Mental Health Nursing, 5th Edition. Wolters Kluwer Health. Lippincott Wiliams & Wilkins.

Whiteford, H.A., Degenhardt, L., Rehm, J., Baxter, A.J., et al. 2013. Global Burden of Disease Attributable to Mental and Substance Use Disorders: Findings from the Global Burden of Disease Study 2010. Journal NCBI, 382(9904): 1575-86.

Wittchen, H.U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., et al. 2011. The Size and Burden of Mental Disorders and Other Disorders of the Brain in Europe 2010. Eur Neuropsychopharmacol, 21(9): 655–79.




DOI: https://doi.org/10.24198/jf.v16i1.17446

DOI (PDF): https://doi.org/10.24198/jf.v16i1.17446.g8635

Refbacks

  • Saat ini tidak ada refbacks.




Sitasi manajer:   

 

 

Jurnal ini diindeks dalam:

 

 

View My Stats 

ISSN: 1693-1424

e-ISSN: 2716-3075

 

Farmaka by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Copyright © 2013 Jurnal Farmaka - All Right Reserved